The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
In-depth interviews from Tanzania suggest relationship dynamics and stigma are the biggest influencers on PrEP use.
Study among teenagers living with HIV in Johannesburg finds 9% have a mental health issue – and are more likely to be virally unsuppressed than others
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months
User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.
Study among fisherfolk, sex workers, truck drivers and others at higher risk of HIV finds many are willing to try PrEP – but only for around six weeks.
The proportion of South Africans ever testing for HIV increased from 30% to 75% between 2005 and 2017 – but differences remain in who is getting tested
We have launched a new mobile app made in collaboration with community health workers in Southern Africa. Find out all you need to know about Boost!
Mobile testing and door-to-door approaches result in a 25% increase in status awareness, with particularly significant gains in diagnosing HIV-positive young people and men.
An evaluation of Zvandiri, a teen-led programme for HIV-positive adolescents in Zimbabwe, finds it significantly improves treatment outcomes and boosts self-esteem.
